By expenditures
| Name | Title | Type |
|---|---|---|
| Mark Barry | GRANTS COORDINATOR | Auditee |
| Andrea Caladie | Principal | Auditee |
| Jeffrey Weiss | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365027 | 2023 | 2025-08-27 | Baker Tilly US LLP | $19.90M |
| 299196 | 2022 | 2024-03-28 | Zelenkofske Axelrod LLC | $14.49M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365027 | 2023 | 2025-08-27 | 1151167 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151166 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151165 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151164 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151163 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151162 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151161 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151160 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151159 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 1151158 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574725 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574724 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574723 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574722 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574721 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574720 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574719 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574718 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574717 | 2023-003 | Significant Deficiency | - | L |
| 365027 | 2023 | 2025-08-27 | 574716 | 2023-003 | Significant Deficiency | - | L |